Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kenvue, Inc. ( (KVUE) ) has shared an announcement.
On November 2, 2025, Kenvue Inc. entered into a merger agreement with Kimberly-Clark Corporation, which will see Kenvue become a wholly owned subsidiary of Kimberly-Clark. This strategic merger, valued at approximately $48.7 billion, aims to create a global health and wellness leader by combining complementary product portfolios and leveraging both companies’ strengths. The merger is expected to deliver significant synergies and value creation for shareholders, with the transaction anticipated to close in the second half of 2026. Additionally, Kirk L. Perry was appointed as Kenvue’s permanent CEO, effective immediately, following his interim role since July 2025.
The most recent analyst rating on (KVUE) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Kenvue, Inc. stock, see the KVUE Stock Forecast page.
Spark’s Take on KVUE Stock
According to Spark, TipRanks’ AI Analyst, KVUE is a Neutral.
Kenvue’s overall stock score is influenced by stable financial performance and strong cash flow management. However, bearish technical indicators, disappointing earnings call results, and a high dividend yield reflecting potential risks contribute to a cautious outlook.
To see Spark’s full report on KVUE stock, click here.
More about Kenvue, Inc.
Kenvue Inc. is a global consumer health leader, known for its science-backed innovation and healthcare professional network. The company operates in the consumer health industry, offering a range of products that cater to health and wellness needs across various life stages.
Average Trading Volume: 30,795,076
Technical Sentiment Signal: Sell
Current Market Cap: $27.58B
See more data about KVUE stock on TipRanks’ Stock Analysis page.